503 related articles for article (PubMed ID: 33718125)
21. A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer.
Zhu Z; Chen M; Hu G; Pan Z; Han W; Tan W; Zhou Z; Wang M; Mao L; Li X; Sui X; Song L; Xu Y; Song W; Yu Y; Jin Z
Eur Radiol; 2023 Jun; 33(6):3918-3930. PubMed ID: 36515714
[TBL] [Abstract][Full Text] [Related]
22. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
[TBL] [Abstract][Full Text] [Related]
23.
Polverari G; Ceci F; Bertaglia V; Reale ML; Rampado O; Gallio E; Passera R; Liberini V; Scapoli P; Arena V; Racca M; Veltri A; Novello S; Deandreis D
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380754
[TBL] [Abstract][Full Text] [Related]
24. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
[TBL] [Abstract][Full Text] [Related]
25. Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Tonneau M; Phan K; Manem VSK; Low-Kam C; Dutil F; Kazandjian S; Vanderweyen D; Panasci J; Malo J; Coulombe F; Gagné A; Elkrief A; Belkaïd W; Di Jorio L; Orain M; Bouchard N; Muanza T; Rybicki FJ; Kafi K; Huntsman D; Joubert P; Chandelier F; Routy B
Front Oncol; 2023; 13():1196414. PubMed ID: 37546399
[TBL] [Abstract][Full Text] [Related]
26. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
27. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
29. Computer-aided diagnosis of ground glass pulmonary nodule by fusing deep learning and radiomics features.
Hu X; Gong J; Zhou W; Li H; Wang S; Wei M; Peng W; Gu Y
Phys Med Biol; 2021 Mar; 66(6):065015. PubMed ID: 33596552
[TBL] [Abstract][Full Text] [Related]
30. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
31. Application of radiomics signature captured from pretreatment thoracic CT to predict brain metastases in stage III/IV ALK-positive non-small cell lung cancer patients.
Xu X; Huang L; Chen J; Wen J; Liu D; Cao J; Wang J; Fan M
J Thorac Dis; 2019 Nov; 11(11):4516-4528. PubMed ID: 31903240
[TBL] [Abstract][Full Text] [Related]
32. Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images.
Chang R; Qi S; Yue Y; Zhang X; Song J; Qian W
Front Oncol; 2021; 11():646190. PubMed ID: 34307127
[TBL] [Abstract][Full Text] [Related]
33. Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment.
Flaus A; Habouzit V; de Leiris N; Vuillez JP; Leccia MT; Simonson M; Perrot JL; Cachin F; Prevot N
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204479
[TBL] [Abstract][Full Text] [Related]
34. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
[TBL] [Abstract][Full Text] [Related]
35. Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients.
Granata V; Fusco R; Costa M; Picone C; Cozzi D; Moroni C; La Casella GV; Montanino A; Monti R; Mazzoni F; Grassi R; Malagnino VG; Cappabianca S; Grassi R; Miele V; Petrillo A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439148
[TBL] [Abstract][Full Text] [Related]
36. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma.
Li HM; Gong J; Li RM; Xiao ZB; Qiang JW; Peng WJ; Gu YJ
AJR Am J Roentgenol; 2021 Sep; 217(3):664-675. PubMed ID: 34259544
[No Abstract] [Full Text] [Related]
37. Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.
Yolchuyeva S; Ebrahimpour L; Tonneau M; Lamaze F; Orain M; Coulombe F; Malo J; Belkaid W; Routy B; Joubert P; Manem VS
J Transl Med; 2024 Jan; 22(1):42. PubMed ID: 38200511
[TBL] [Abstract][Full Text] [Related]
38. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
[TBL] [Abstract][Full Text] [Related]
39. A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer.
Yang Y; Yang J; Shen L; Chen J; Xia L; Ni B; Ge L; Wang Y; Lu S
Am J Transl Res; 2021; 13(2):743-756. PubMed ID: 33594323
[TBL] [Abstract][Full Text] [Related]
40. Radiomics of Tumor Heterogeneity in
Ventura D; Schindler P; Masthoff M; Görlich D; Dittmann M; Heindel W; Schäfers M; Lenz G; Wardelmann E; Mohr M; Kies P; Bleckmann A; Roll W; Evers G
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
